Home › Companies › BLUEPRINT MEDICINES CORP. › 2024-2025
Compiled from SEC Form N-PX filings and BLUEPRINT MEDICINES CORP.’s Form 8-K, filed June 20, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of June 18, 2025: 5 items on BLUEPRINT MEDICINES CORP.’s Form 8-K, filed June 20, 2025: 2 approved · 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore BLUEPRINT MEDICINES CORP. in the interactive database Compare manager voting policies
These tallies are BLUEPRINT MEDICINES CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 20, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jeffery W. Albers | 44,683,223 | -- | -- | 15,507,415 | 2,342,656 | 74% | Not verified | — |
| Elect Director: Mark Goldberg, M.D. | 46,734,594 | -- | -- | 13,456,044 | 2,342,656 | 78% | Not verified | — |
| Elect Director: John Tsai, M.D. | 47,572,890 | -- | -- | 12,617,748 | 2,342,656 | 79% | Not verified | — |
| 2. The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers. | 57,714,069 | 2,450,825 | 25,744 | -- | 2,342,656 | 96% | Approved | — |
| 3. The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting for the fiscal year ending December 31, 2025. | 62,209,853 | 288,580 | 34,861 | -- | -- | 99.5% | Approved | — |
Source: BLUEPRINT MEDICINES CORP., Form 8-K, filed with the SEC on June 20, 2025 — read the filing on EDGAR.
Each item below shows how the 373 asset managers that disclosed a BLUEPRINT MEDICINES CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: Jeffrey Albers
BLUEPRINT MEDICINES CORP.’s own tally for this item (“Elect Director: Jeffery W. Albers”): 44,683,223 for, 15,507,415 withheld, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 101 asset managers below reported 28,128,126 for, 5,085,675 withheld, 519,354 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,346,069 | 0 | 0 | 2,400 | For |
| T. Rowe Price | 5,315,475 | 0 | 0 | 21,550 | For |
| BlackRock | 2,524,631 | 0 | 0 | 0 | For |
| Fidelity | 2,339,724 | 0 | 0 | 200 | For |
| JPMorgan | 2,017,498 | 0 | 0 | 0 | For |
| State Street | 3,339 | 0 | 0 | 1,158,395 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 955,278 | Withhold |
| MUTUAL FUND SERIES TRUST | 859,462 | 0 | 0 | 0 | For |
| Invesco | 621,899 | 0 | 0 | 0 | For |
| Charles Schwab | 604,993 | 0 | 0 | 0 | For |
| TIAA | 543,580 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 519,074 | 0 | 0 | 0 | For |
| Jackson National | 381,683 | 0 | 112,784 | 0 | Mixed |
| ACAP Strategic Fund | 0 | 0 | 0 | 444,988 | Withhold |
| AllianceBernstein | 382,517 | 0 | 0 | 0 | For |
| Capital Group | 367,124 | 0 | 0 | 0 | For |
| Legg Mason | 342,300 | 0 | 0 | 3,400 | For |
| American Century | 0 | 0 | 0 | 342,227 | Withhold |
| Columbia Threadneedle | 336,059 | 0 | 0 | 0 | For |
| Goldman Sachs | 291,734 | 0 | 0 | 20,507 | Mixed |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 298,044 | Withhold |
| Equitable | 271,202 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 260,458 | Withhold |
| Principal | 77,655 | 0 | 0 | 148,280 | Mixed |
| AB DISCOVERY GROWTH FUND, INC. | 207,703 | 0 | 0 | 0 | For |
Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.
Combines 6 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: John Tsai, M.D.
BLUEPRINT MEDICINES CORP.’s own tally for this item (“Elect Director: John Tsai, M.D.”): 47,572,890 for, 12,617,748 withheld, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 101 asset managers below reported 29,526,743 for, 3,707,678 withheld, 498,734 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,346,069 | 0 | 0 | 2,400 | For |
| T. Rowe Price | 5,315,475 | 0 | 0 | 21,550 | For |
| BlackRock | 2,524,631 | 0 | 0 | 0 | For |
| Fidelity | 2,339,724 | 0 | 0 | 200 | For |
| JPMorgan | 2,017,498 | 0 | 0 | 0 | For |
| State Street | 1,160,253 | 0 | 0 | 1,481 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 955,278 | Withhold |
| MUTUAL FUND SERIES TRUST | 859,462 | 0 | 0 | 0 | For |
| Invesco | 621,899 | 0 | 0 | 0 | For |
| Charles Schwab | 604,993 | 0 | 0 | 0 | For |
| TIAA | 543,580 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 519,074 | 0 | 0 | 0 | For |
| Jackson National | 381,683 | 0 | 112,784 | 0 | Mixed |
| ACAP Strategic Fund | 0 | 0 | 0 | 444,988 | Withhold |
| AllianceBernstein | 382,517 | 0 | 0 | 0 | For |
| Capital Group | 367,124 | 0 | 0 | 0 | For |
| Legg Mason | 342,300 | 0 | 0 | 3,400 | For |
| American Century | 0 | 0 | 0 | 342,227 | Withhold |
| Columbia Threadneedle | 336,059 | 0 | 0 | 0 | For |
| Goldman Sachs | 291,734 | 0 | 0 | 20,507 | Mixed |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 298,044 | Withhold |
| Equitable | 271,202 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 260,458 | Withhold |
| Principal | 77,655 | 0 | 0 | 148,280 | Mixed |
| AB DISCOVERY GROWTH FUND, INC. | 207,703 | 0 | 0 | 0 | For |
Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.
Combines 6 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: Mark Goldberg, M.D.
BLUEPRINT MEDICINES CORP.’s own tally for this item (“Elect Director: Mark Goldberg, M.D.”): 46,734,594 for, 13,456,044 withheld, per its Form 8-K filed June 20, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 101 asset managers below reported 29,487,026 for, 3,726,775 withheld, 519,354 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,346,069 | 0 | 0 | 2,400 | For |
| T. Rowe Price | 5,315,475 | 0 | 0 | 21,550 | For |
| BlackRock | 2,524,631 | 0 | 0 | 0 | For |
| Fidelity | 2,339,724 | 0 | 0 | 200 | For |
| JPMorgan | 2,017,498 | 0 | 0 | 0 | For |
| State Street | 1,160,253 | 0 | 0 | 1,481 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 955,278 | Withhold |
| MUTUAL FUND SERIES TRUST | 859,462 | 0 | 0 | 0 | For |
| Invesco | 621,899 | 0 | 0 | 0 | For |
| Charles Schwab | 604,993 | 0 | 0 | 0 | For |
| TIAA | 543,580 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 519,074 | 0 | 0 | 0 | For |
| Jackson National | 381,683 | 0 | 112,784 | 0 | Mixed |
| ACAP Strategic Fund | 0 | 0 | 0 | 444,988 | Withhold |
| AllianceBernstein | 382,517 | 0 | 0 | 0 | For |
| Capital Group | 367,124 | 0 | 0 | 0 | For |
| Legg Mason | 342,300 | 0 | 0 | 3,400 | For |
| American Century | 0 | 0 | 0 | 342,227 | Withhold |
| Columbia Threadneedle | 336,059 | 0 | 0 | 0 | For |
| Goldman Sachs | 291,734 | 0 | 0 | 20,507 | Mixed |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 298,044 | Withhold |
| Equitable | 271,202 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 260,458 | Withhold |
| Principal | 77,655 | 0 | 0 | 148,280 | Mixed |
| AB DISCOVERY GROWTH FUND, INC. | 207,703 | 0 | 0 | 0 | For |
Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.
Combines 10 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: APPROVAL OF A NON-BINDING ADVISORY VOTE ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
BLUEPRINT MEDICINES CORP.’s own tally for this item (“2. The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”): 57,714,069 for, 2,450,825 against — passed, per its Form 8-K filed June 20, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,348,466 | 3 | 0 | 0 | For |
| T. Rowe Price | 5,337,025 | 0 | 0 | 0 | For |
| BlackRock | 2,524,631 | 0 | 0 | 0 | For |
| Fidelity | 2,339,924 | 0 | 0 | 0 | For |
| JPMorgan | 2,017,498 | 0 | 0 | 0 | For |
| State Street | 1,160,241 | 1,493 | 0 | 0 | For |
| Delaware/Macquarie | 955,278 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 859,462 | 0 | 0 | 0 | For |
| Invesco | 0 | 621,899 | 0 | 0 | Against |
| Charles Schwab | 604,993 | 0 | 0 | 0 | For |
| TIAA | 543,580 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 519,074 | 0 | 0 | 0 | For |
| Jackson National | 370,266 | 124,201 | 0 | 0 | Mixed |
| ACAP Strategic Fund | 444,988 | 0 | 0 | 0 | For |
| AllianceBernstein | 382,517 | 0 | 0 | 0 | For |
| Capital Group | 367,124 | 0 | 0 | 0 | For |
| Legg Mason | 345,700 | 0 | 0 | 0 | For |
| American Century | 0 | 342,227 | 0 | 0 | Against |
| Columbia Threadneedle | 336,059 | 0 | 0 | 0 | For |
| Goldman Sachs | 312,241 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 298,044 | 0 | 0 | 0 | For |
| Equitable | 271,202 | 0 | 0 | 0 | For |
| MFS | 260,458 | 0 | 0 | 0 | For |
| Principal | 225,935 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 207,703 | 0 | 0 | 0 | For |
Fund voting reports, all 101 managers: 32,444,098 for, 1,244,963 against, 19,018 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 7,650,806 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 3,863,022 | 0 | 0 | 0 | For |
| JPMorgan | 2,968,883 | 0 | 0 | 0 | For |
| Wellington | 2,595,811 | 0 | 0 | 0 | For |
| State Street | 2,402,619 | 2,420 | 0 | 0 | For |
| BlackRock | 2,318,159 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,532,467 | 0 | 0 | 0 | For |
| Fidelity | 1,255,565 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1,228,220 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 1,167,237 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,094,841 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 889,570 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 865,256 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 772,960 | 0 | 0 | 0 | For |
| Invesco | 0 | 740,036 | 0 | 0 | Against |
| Clearbridge Investments, LLC | 673,915 | 0 | 0 | 0 | For |
| American Century | 0 | 628,907 | 0 | 0 | Against |
| Siren, L.L.C. | 623,870 | 0 | 0 | 0 | For |
| Charles Schwab | 617,403 | 0 | 0 | 0 | For |
| Nuveen | 590,204 | 0 | 0 | 0 | For |
| Northern Trust | 497,330 | 0 | 0 | 0 | For |
| BROWN ADVISORY INC | 488,364 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 445,736 | 0 | 0 | 0 | For |
| Woodline Partners LP | 418,873 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 367,124 | 0 | 0 | 0 | For |
Institutional-manager reports, all 297 managers: 43,293,172 for, 1,841,469 against, 25,100 withheld, 1,490 abstained, 1,659 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.5% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
BLUEPRINT MEDICINES CORP.’s own tally for this item (“3. The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting for the fiscal year ending December 31, 2025.”): 62,209,853 for, 288,580 against — passed, per its Form 8-K filed June 20, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting for the fiscal year ending December 31, 2025.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 103 asset managers below reported 33,702,990 for, 12,323 against, 19,018 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,348,469 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,337,025 | 0 | 0 | 0 | For |
| BlackRock | 2,524,631 | 0 | 0 | 0 | For |
| Fidelity | 2,339,924 | 0 | 0 | 0 | For |
| JPMorgan | 2,017,498 | 0 | 0 | 0 | For |
| State Street | 1,161,666 | 68 | 0 | 0 | For |
| Delaware/Macquarie | 955,278 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 859,462 | 0 | 0 | 0 | For |
| Invesco | 621,899 | 0 | 0 | 0 | For |
| Charles Schwab | 604,993 | 0 | 0 | 0 | For |
| TIAA | 543,580 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 519,074 | 0 | 0 | 0 | For |
| Jackson National | 494,467 | 0 | 0 | 0 | For |
| ACAP Strategic Fund | 444,988 | 0 | 0 | 0 | For |
| AllianceBernstein | 382,517 | 0 | 0 | 0 | For |
| Capital Group | 367,124 | 0 | 0 | 0 | For |
| Legg Mason | 345,700 | 0 | 0 | 0 | For |
| American Century | 342,227 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 336,059 | 0 | 0 | 0 | For |
| Goldman Sachs | 312,241 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 298,044 | 0 | 0 | 0 | For |
| Equitable | 271,202 | 0 | 0 | 0 | For |
| MFS | 260,458 | 0 | 0 | 0 | For |
| Principal | 225,935 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 207,703 | 0 | 0 | 0 | For |
Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 64,582,163 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.93% |
| 2 | T. Rowe Price | 8.26% |
| 3 | BlackRock | 3.91% |
| 4 | Fidelity | 3.62% |
| 5 | JPMorgan | 3.12% |
| 6 | State Street | 1.80% |
| 7 | Delaware/Macquarie | 1.48% |
| 8 | MUTUAL FUND SERIES TRUST | 1.33% |
| 9 | Invesco | 0.96% |
| 10 | Charles Schwab | 0.94% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 11.85% |
| 2 | Avoro Capital Advisors LLC | 5.98% |
| 3 | JPMorgan | 4.60% |
| 4 | Wellington | 4.02% |
| 5 | State Street | 3.72% |
| 6 | BlackRock | 3.59% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.37% |
| 8 | Fidelity | 1.94% |
| 9 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.90% |
| 10 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 1.81% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 10.39% | 13F |
| Vanguard Group | 10.28% | 13F |
| T. Rowe Price | 8.39% | 13F |
| Pentwater Capital Management LP | 6.04% | 13G |
| Wellington Management | 4.76% | 13F |
| State Street | 4.16% | 13F |
| JPMorgan Chase | 3.88% | 13F |
| Geode Capital | 2.36% | 13F |
| FMR (Fidelity) | 2.22% | 13F |
| Invesco | 1.52% | 13F |
Percentages above are of 64,582,163 shares outstanding, as reported by BLUEPRINT MEDICINES CORP. on its Form 10-Q dated April 29, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BLUEPRINT MEDICINES CORP.’s 10-Q dated April 29, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At BLUEPRINT MEDICINES CORP.'s shareholder meeting held June 18, 2025, in the 2024-2025 proxy season, 373 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 2,537 separate fund positions. On the most widely held item on that ballot — APPROVAL OF A NON-BINDING ADVISORY VOTE ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE… — BLUEPRINT MEDICINES CORP.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BLUEPRINT MEDICINES CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 20, 2025.
BLUEPRINT MEDICINES CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page).
Download data (CSV): ballot items · votes by manager · column guide.